CS logo
small CS logo
Bendheim Cancer Center

Greenwich, Connecticut, United States
Cancer treatment center in Greenwich, Connecticut
77 Lafayette Pl, Greenwich, CT 06830

About Bendheim Cancer Center


"The Smilow Cancer Hospital Care Center on the Greenwich Hospital campus provides access to expert cancer care and treatment to patients from lower Fairfield County, Connecticut, and Westchester County, New York. Comprehensive outpatient cancer services, including consultation, screening, diagnosis, treatment and follow-up care are located in the Bendheim building. Surgery, if necessary, is performed in the main hospital. Cancer patients who are admitted to Greenwich Hospital are cared for by specially trained staff on a dedicated oncology unit."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Bendheim Cancer Center


During the past decade, Bendheim Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Bendheim Cancer Center


According to Clinical.Site data, the most researched conditions in "Bendheim Cancer Center" are "Alzheimer Disease" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Bendheim Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Bendheim Cancer Center


Most popular intervention types in "Bendheim Cancer Center" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "bapineuzumab" (2 trials), "placebo" (2 trials), "Docetaxel" (1 trials), "SGN-15" (1 trials) and "SGN-15 (cBR96-doxorubicin immunoconjugate)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Bendheim Cancer Center


The vast majority of trials in "Bendheim Cancer Center" are 3 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Bendheim Cancer Center


Currently, there are NaN active trials in "Bendheim Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Bendheim Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Bendheim Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".